China closing in but US leads in biotech quality, commercial reach, survey finds
SAN DIEGO, June 22 (Reuters) - China, which now conducts more clinical drug trials, opens new tab than the U.S., still lags in the quality and commercial reach of its biomedical science, according to a recent survey, opens new tab of senior U.S. leaders in industry and academia. The poll, conducted by Cure Innovation Index, found that China is seen [...]









